![]() |
![]() |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
|
![]() | |||
![]() | |||
![]() | |||
![]() | |||
![]() | |||
![]() |
![]() |
NIH Radio |
|
![]() |
![]() |
![]() |
Experimental Shingles Vaccine Proves Effective Brief Description: Transcript: Straus: We can reduce shingles by 51-percent with a single dose of the vaccine. And, of the individuals who are vaccinated that got shingles, their cases were milder — with much less pain. And, it's pain that's the major problem of shingles, that we dread — which is why we need to prevent it. Schmalfeldt: Doctor Straus summed up the vaccine's potential impact. Straus: For the first time, we have the ability not to treat the shingles — we've had that for 20 years — but to prevent it entirely. We estimate that, if every healthy American age 60 and up got a single dose of the shingles vaccine, we'd prevent a quarter of a million cases of this painful virus infection, every year. Schmalfeldt: The trial was conducted at 22 study sites nationwide — including 16 VA Medical Centers, and six sites coordinated through the NIAID. Shingles is caused by reactivation of the virus that causes chicken-pox. Experts estimate more than a million new cases of shingles occur in the U.S. each year. The vaccine must be approved for use by the Food and Drug Administration before it can be offered on a clinical basis. From the National Institutes of Health, I'm Bill Schmalfeldt, in Bethesda, Maryland. |
![]() |
![]() |
![]() |
|
This page was last reviewed on October 24, 2005 . |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
National Institutes of Health (NIH) |
![]() |
![]() |